Feraheme

Type: Product
Name: Feraheme
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

AMAG Up on Roughly $1B deal with Lumara to Widen Portfolio

Shares of AMAG Pharmaceuticals, Inc. ( AMAG - Snapshot Report ) soared 28.2% after it announced that it will be acquiring privately held Lumara Health Inc. for approximately $1 billion in order to diversify its portfolio. The transaction, approved by ... [Published Zacks.com - Sep 30 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Amag Pharmaceuticals to buy Lumara Health for $675m

Amag Pharmaceuticals has signed an agreement to acquire a privately held maternal health pharmaceutical company, Lumara Health, for $675m.The deal also includes an additional contingent consideration of up to $350m based on achievement of certain sales ... [Published Pharmaceutical Technology - Sep 30 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Amag buys into maternal health business

Will acquire female health specialist Lumara HealthAmag Pharmaceuticals has agreed to pay $675m-plus to buy female health specialist Lumara Health in a deal that will see the latter firm broken up.The transaction will also see the remainder of Lumara's ... [Published PMLive - Sep 30 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

AMAG Pharma Appoints Pharmacovigilance VP

Judith Johnson, M.D. , has rejoined AMAG Pharmaceuticals as vice president of pharmacovigilance and pharmacoepidemiology, responsible for all pharmacovigilance functions, including product safety surveillance, aggregate safety reporting, pharmacoepidemiology ... [Published Contract Pharma - Sep 16 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 1 reports

AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors

WALTHAM, Mass., Sept. 8, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. ( Nasdaq:AMAG ) today announced that John Fallon, M.D., senior vice president and chief physician executive at Blue Cross & Blue Shield of Massachusetts (BCBSMA), has been elected ... [Published Fat Pitch Financials - Sep 08 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

WALTHAM, Mass., Aug. 29, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. ( Nasdaq:AMAG ) today announced that company management will discuss AMAG's business and financial outlook, strategy and growth prospects at investor conferences taking place ... [Published Street Sweeper - Aug 29 2014]
First reported Jun 09 2014 - Updated Jun 09 2014 - 1 reports

AMAG Pharma gets patent term extension for ferumoxytol injection in US

AMAG Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) has issued a US patent term extension certificate extending the term of US Patent No. 6,599,498 by 1,209 days.With this extension the '498 patent will now expire 30 June ... [Published Pharmaceutical Business Review - Jun 09 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

AMAG Announces First Quarter 2014 Financial Results

17% Total Revenue Growth, Driven by Strong Feraheme PerformanceFavorable Terms Achieved in Recent $200 Million Convertible Debt OfferingEnding Cash Balance of $385 Million Provides Capital for Portfolio ExpansionConference call scheduled for 8:00 a.m. ... [Published GlobeNewswire - Apr 24 2014]

Quotes

"We believe the Lumara Health transaction will facilitate future product acquisitions in an attractive new therapeutic area and is an excellent strategic fit with our Feraheme market expansion plans."
"If every eligible patient were treated with Makena, this represents greater than a $1 billion market potential" Heiden said
"This is a truly transformative transaction that will propel AMAG into a profitable, high-growth multi-product specialty pharmaceutical company" remarked CEO William Heiden...
...partner to support the continued growth of Makena and our maternal health business," said Greg Divis, chief executive officer of Lumara Health.  "This transaction is a great reflection of the outstanding work our team has done to build the maternal health franchise to what it is today, and I am pleased that this same team will continue to grow the brand within AMAG. It has been clear from the start of our discussions that AMAG shares our commitment to at-risk pregnant mothers, their babies and their healthcare providers."

More Content

All (25) | News (24) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
AMAG Up on Roughly $1B deal with Lumara to Wide... [Published Zacks.com - Sep 30 2014]
Amag Pharmaceuticals to buy Lumara Health for $... [Published Pharmaceutical Technology - Sep 30 2014]
Amag buys into maternal health business [Published PMLive - Sep 30 2014]
Amag $1 billion deal to buy preterm birth drug ... [Published Pharma Times - Sep 30 2014]
Amag Pharma enters women health business with $... [Published Yahoo! News - Sep 29 2014]
AMAG Pharmaceuticals, Inc. Shells Out $675 Mill... [Published BioSpace - Sep 29 2014]
AMAG Pharmaceuticals to buy Lumara's maternal h... [Published FirstWord Pharma - Sep 29 2014]
Troubled AMAG snaps up fresh-from-bankruptcy Lu... [Published FiercePharma - Sep 29 2014]
Amag agrees to buy Lumara’s maternal health bus... [Published Boston Globe - Sep 29 2014]
Lumara Health™ to be Acquired in Two Separate T... [Published Stockwatch - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health M... [Published Virtual Strategy Magazine - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health -3- [Published Scottrade - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health M... [Published Scottrade - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health -2- [Published Scottrade - Sep 29 2014]
AMAG Pharma Appoints Pharmacovigilance VP [Published Contract Pharma - Sep 16 2014]
AMAG Pharmaceuticals Appoints Judith Johnson, M... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
AMAG Pharmaceuticals Appoints Judith Johnson, M... [Published Industrial Info Financials - Sep 16 2014]
AMAG Pharmaceuticals Announces Appointment of J... [Published Virtual Strategy Magazine - Sep 08 2014]
AMAG Pharmaceuticals Announces Appointment of J... [Published Fat Pitch Financials - Sep 08 2014]
AMAG Pharmaceuticals, Inc. to Present at Upcomi... [Published Street Sweeper - Aug 29 2014]
AMAG Pharma gets patent term extension for feru... [Published Pharmaceutical Business Review - Jun 09 2014]
AMAG Announces First Quarter 2014 Financial Res... [Published GlobeNewswire - Apr 24 2014]
AMAG Pharmaceuticals Announces Proposed Offerin... [Published GlobeNewswire - Feb 10 2014]
AMAG Pharma's ferumoxytol gets new US patent [Published PharmaBiz - Feb 04 2014]
AMAG Pharmaceuticals gets new US patent for fer... [Published Pharmaceutical Business Review - Feb 03 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
AMAG Pharmaceuticals Appoints Judith Johnson, M... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.